Yahoo! Finance Canada report covering MetLife Inc. (MET) market action, institutional positioning, and fundamental catalysts.
Why MET Stock slipped -0.80% Today — RQD Quant Desk Flash
MetLife Inc. (MET) earns a Roarable Rating of B (Buy) with 72/100 RQD Confidence. High-quality cash engine (steady margins, 2% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is MET stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-02, MetLife Inc. (NYSE: MET) is rated B (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 72/100 at a spot price of $100.02 (-0.80% 1D, market cap $64.08B). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 17/20, Executive Insider Alignment 15/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 14/20. Across 1096 tracked Financials issuers, MET ranks #72 in composite RQD confidence.
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does MET compare to MFC and SLF in the Financials sector?
▼
Within the Financials sector (Life Insurance), MET carries a Roarable B (72/100 RQD), trailing P/E of 20.2x, gross margin of —, and ROIC of 1.6%. By comparison, MFC (Manulife Financial Corporation) holds a C grade (64/100 RQD, P/E 32.8x, ROIC 9.9%, cap $75.52B) and SLF (Sun Life Financial Inc.) posts a C grade (64/100 RQD, P/E 32.8x, ROIC 9.9%, cap $45.56B). Among the 5-stock peer group, PRU leads on earnings multiple (11.3x) while PRU leads on capital efficiency (10.9% ROIC).
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for MET?
▼
Per MET's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001099219), MetLife Inc. generated $2.44B in revenue (+8.5% YoY), $3.17B in net income, and $16.98B in free cash flow against $745.17B in total assets and $322.31B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
20D Institutional Volume Accumulation (±4% realized swing band)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9
Macro rate sensitivity & RSI-14 (55.6) create a -7 pt regime headwind
⚔️ Adversarial Opposing Case: Why the MET Bull Thesis Could Fail
Even with a 72/100 (B) score, MET faces multiple-compression risk if 20.2x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
Broader market pullbacks can still drag down strong stocks in the short run.
Dilution & Margin Drag: Cannibal Buyback (-1.80% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($97.90) or 200D SMA ($85.92) invalidates the momentum regime and cuts Target Base ($106.32) toward Bear Floor ($82.02).
Why MET Stock slipped -0.80% Today — RQD Quant Desk Flash
MetLife Inc. (MET) slipped -0.80% to $100.02, trading at 90% of its 52-week range ($67.33 – $103.65). High-quality cash engine (steady margins, 2% return on capital) with steady institutional support.
- ▸Technical Tape: Trading at 90% of its 52-week range ($67.33 – $103.65) with RSI-14 at 55.6 (BULLISH MOMENTUM).
- ▸Volatility Profile: Historical 20-day realized swing band of ±4% around $100.02 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable B (Buy) backed by 52% gross margin and $17.0B annual free cash flow.
Yahoo Finance report covering MetLife Inc. (MET) market action, institutional positioning, and fundamental catalysts.
ChartMill report covering MetLife Inc. (MET) market action, institutional positioning, and fundamental catalysts.
Fortune report covering MetLife Inc. (MET) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering MetLife Inc. (MET) market action, institutional positioning, and fundamental catalysts.
Seeking Alpha report covering MetLife Inc. (MET) market action, institutional positioning, and fundamental catalysts.
The Globe and Mail report covering MetLife Inc. (MET) market action, institutional positioning, and fundamental catalysts.
TradingView report covering MetLife Inc. (MET) market action, institutional positioning, and fundamental catalysts.
Get a weekly dividend summary for Champions, Contenders, and Challengers.
Evaluate the expected performance of MetLife (MET) for the quarter ended September 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Scheduled RQD Strong Buys & Whale Accumulation Briefing (MET Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
MET Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +8.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on MET today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for MET. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (MET)
1. Head-to-Head Financials Peer Comparison (MET vs. MFC, SLF, PRU, PUK)
Industry: Life Insurance (18 Tracked Issuers)Across 1096 tracked Financials securities in the Roarable RQD universe, MetLife Inc. (MET) ranks #72 by composite RQD confidence (72/100, grade B) and #58 by equity capitalization ($64.08B). Within this direct 5-issuer industry benchmark cohort, PRU leads on earnings valuation at 11.3x trailing P/E, while PRU leads on capital efficiency and profitability with 10.9% ROIC and — gross margin. MET currently leads its immediate peer cohort in composite quantitative strength at 72/100 (B).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| MET
ACTIVE
MetLife Inc. | B | 72/100 | 20.2x | — | 1.6% | -0.80% | $64.08B | Benchmark Subject |
| MFC Manulife Financial Corporation | C | 64/100 | 32.8x | — | 9.9% | -1.37% | $75.52B | /mfc-vs-met → |
| SLF Sun Life Financial Inc. | C | 64/100 | 32.8x | — | 9.9% | -1.10% | $45.56B | /slf-vs-met → |
| PRU Prudential Financial Inc. | C+ | 69/100 | 11.3x | — | 10.9% | -0.36% | $40.32B | /pru-vs-met → |
| PUK Prudential Public Limited Company | D | 50/100 | 32.8x | — | 9.9% | +1.27% | $30.48B | /puk-vs-met → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001099219In its most recent audited fiscal period (FY2025, filed 2025-12-31), MetLife Inc. (MET) reported GAAP revenue of $2.44B (+8.5% vs. FY2024 revenue of $2.25B , and +9.3% cumulative change since FY2023) , GAAP net income of $3.17B, operating cash flow of $17.09B, and free cash flow of $16.98B (+17.1% YoY). On the balance sheet, MET closed FY2025 with $745.17B in total assets against $322.31B in total debt (Altman Z-Score: N/A, Piotroski F-Score: 7/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $2.44B | $3.17B | $17.09B | $16.98B | $745.17B | $322.31B |
| FY2024 (FY) | 2024-12-31 | $2.25B | $4.23B | $14.60B | $14.50B | $677.46B | $292.39B |
| FY2023 (FY) | 2023-12-31 | $2.23B | $1.38B | $13.72B | $13.62B | $35.24B | $8.25B |
3. MET Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs MET stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-02, MetLife Inc. (NYSE: MET) is rated B (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 72/100 at a spot price of $100.02 (-0.80% 1D, market cap $64.08B). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 17/20, Executive Insider Alignment 15/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 14/20. Across 1096 tracked Financials issuers, MET ranks #72 in composite RQD confidence.
How does MET compare to MFC and SLF in the Financials sector?
Within the Financials sector (Life Insurance), MET carries a Roarable B (72/100 RQD), trailing P/E of 20.2x, gross margin of —, and ROIC of 1.6%. By comparison, MFC (Manulife Financial Corporation) holds a C grade (64/100 RQD, P/E 32.8x, ROIC 9.9%, cap $75.52B) and SLF (Sun Life Financial Inc.) posts a C grade (64/100 RQD, P/E 32.8x, ROIC 9.9%, cap $45.56B). Among the 5-stock peer group, PRU leads on earnings multiple (11.3x) while PRU leads on capital efficiency (10.9% ROIC).
What are the biggest fundamental strengths and SEC risk factors for MET?
Per MET's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001099219), MetLife Inc. generated $2.44B in revenue (+8.5% YoY), $3.17B in net income, and $16.98B in free cash flow against $745.17B in total assets and $322.31B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is MET trading relative to its 50-day, 200-day, and 52-week technical levels?
MET last traded at $100.02 (-0.80% on volume of 4,034,360 shares), positioning the stock +2.17% above its 50-day simple moving average ($97.90) and +16.41% above its 200-day simple moving average ($85.92). Across its 52-week range of $67.33 to $103.65, MET sits at the 90.0% percentile with a 14-day RSI of 55.6 (BULLISH MOMENTUM) and an implied next-earnings move of ±4.0% ($96.02 to $104.02).
MET Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is MET stock moving today?
Why MET Stock slipped -0.80% Today — RQD Quant Desk Flash. High-quality cash engine (steady margins, 2% return on capital) with steady institutional support.
MET — MetLife Inc.: What the Facts Mean to a Prospective Investor
Roarable Rating Brief: What This Means to a Prospective Investor
Per the Roarable RQD rating, MET scores 72 out of 100 (grade B, verdict "Roarable Buy — Good Risk/Reward"). The five pillars are:
- Fundamental cash engine: 13 / 20. Per the Roarable RQD rating, this pillar reflects ROIC of 1.6% and an FCF yield of 22%. The combination suggests strong cash generation relative to market value, but very low return on invested capital, which tempers how efficiently that capital is deployed.
- Whale 13F flow: 17 / 20. Per the Roarable RQD rating, this pillar is the strongest and reflects institutional accumulation and options positioning.
- Insider conviction: 14 / 20. Per the Roarable RQD rating, this reflects SEC Form 4 and Congressional PTR cluster flow, scoring moderately well.
- Macro regime fit: 13 / 20. Per the Roarable RQD rating, this reflects a beta of 1.16 and sector sensitivity, indicating above-market price sensitivity.
- Forensic balance sheet: 15 / 20. Per the Roarable RQD rating, this reflects an Altman Z-Score of 2.5, Piotroski F-Score of 7/9, and Debt/Equity of 0.5.
For a prospective investor evaluating the stock today, the rating points to mixed but generally constructive conditions. Institutional positioning and balance-sheet metrics are the main supports. The valuation tradeoff is visible in the market data: trailing P/E of 20.2 versus forward P/E of 18.8 implies expected earnings improvement per the market data, while EV/EBITDA of 55 and ROIC of 1.6% are elevated and weak respectively. Price at 100.83 sits near the top of its 52-week range of $67.33 – $103.65. This is an analytical framing of the scores, not a recommendation.
Snapshot
Recent Catalysts & News Wire Analysis
Per the recent news and catalysts feed, six items relate to MET:
- A market-wire item referencing a stock price, news, and quote page (1h ago).
- A market-wire item announcing a fourth quarter 2026 common stock dividend declaration (3h ago).
- A ChartMill item describing technical strength and a constructive breakout setup (6h ago).
- A Fortune company profile item (9h ago).
- A MarketBeat item on a 2026 stock forecast and price target (12h ago).
- A Seeking Alpha item on momentum into Q3 earnings and a technical breakout (15h ago).
All six items carry a YELLOW light designation and a "MARKET WIRE" impact label. The dividend declaration is the only item with a specific corporate action named in its headline. Per the Butterfly Supply-Chain Graph, no proprietary signals are present.
Open Questions
- What is the composition of revenue and the reason reported revenue ($2436.0M in FY 2025) is far below operating income ($6137.0M), given the gross margin of 0%?
- What drove the increase in reported debt from $8246.5M in FY 2023 to $322310.2M in FY 2025, and how does that align with the Debt/Equity of 0.5?
- Why is EPS reported as N/A across all periods while EPS (TTM) is 4.99?
- What is the source and basis of the 55x EV/EBITDA multiple, and how does it reconcile with the 20.2x trailing P/E?
- Who are the institutional holders and insiders behind the Whale 13F and insider conviction scores?
MET Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for MetLife Inc. (MET) • Click "Debate This Headline" to argue it in the Roar Pit below
Yahoo! Finance Canada report covering MetLife Inc. (MET) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering MetLife Inc. (MET) market action, institutional positioning, and fundamental catalysts.
ChartMill report covering MetLife Inc. (MET) market action, institutional positioning, and fundamental catalysts.
Fortune report covering MetLife Inc. (MET) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering MetLife Inc. (MET) market action, institutional positioning, and fundamental catalysts.
Seeking Alpha report covering MetLife Inc. (MET) market action, institutional positioning, and fundamental catalysts.
The Globe and Mail report covering MetLife Inc. (MET) market action, institutional positioning, and fundamental catalysts.
TradingView report covering MetLife Inc. (MET) market action, institutional positioning, and fundamental catalysts.
MET Bull vs. Bear Conversation Board — What's Your Call at $100.02?
🔥 Official Bull vs. Bear Debate: Is MET (B • RQD 72/100) a Buy at $100.83?
Welcome to the MET (MetLife Inc.) Roar Pit. Current RQD Composite is 72/100 (Roarable Buy — Good Risk/Reward) in Life Insurance. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
Pump the brakes on MET — check the valuation vs. margin headwinds
Everyone in here is repeating the bull case on MET, but look at what you are paying: 20.2x trailing P/E with tightening sector spreads. Unless MetLife Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
MET cash flow & RQD setup is being underpriced by the Street here
Looking at the 5-pillar RQD breakdown on MET, the market is fixating on short-term headline noise in Life Insurance and ignoring the balance sheet and cash flow trajectory. At $100.83 (52-wk range $67.33 - $103.65), any beat on forward guidance forces shorts and underweight funds to chase.